Know How Tresiba Compares to Other Basal Insulins for Type 2 Diabetes
Reps will raise questions about whether insulin degludec (Tresiba, etc) is better than other basal insulins (Lantus, etc) for type 2 diabetes.
They're sharing new data that suggest insulin degludec U-100 has a lower risk of symptomatic hypoglycemia than insulin glargine U-100.
But help put this in perspective.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote